Matthew Byerly

4.0k total citations · 1 hit paper
49 papers, 2.8k citations indexed

About

Matthew Byerly is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Matthew Byerly has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 9 papers in Clinical Psychology and 8 papers in Pharmacology. Recurrent topics in Matthew Byerly's work include Schizophrenia research and treatment (30 papers), Bipolar Disorder and Treatment (14 papers) and Sexual function and dysfunction studies (8 papers). Matthew Byerly is often cited by papers focused on Schizophrenia research and treatment (30 papers), Bipolar Disorder and Treatment (14 papers) and Sexual function and dysfunction studies (8 papers). Matthew Byerly collaborates with scholars based in United States, United Kingdom and Spain. Matthew Byerly's co-authors include Paul A. Nakonezny, A. John Rush, Thomas Carmody, T. Scott Stroup, Joseph P. McEvoy, Robert B. Fisher, Ira D. Glick, G. M. Simpson, Michael C. Stevens and Jeffrey A. Lieberman and has published in prestigious journals such as JAMA, Schizophrenia Bulletin and Journal of Medical Internet Research.

In The Last Decade

Matthew Byerly

48 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

2003 512 citations T. Scott Stroup, Joseph P. McEvoy et al. Schizophrenia Bulletin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Byerly United States	28	1.8k	630	400	345	291	49	2.8k
Petter Andreas Ringen Norway	25	1.7k 1.0×	510 0.8×	211 0.5×	139 0.4×	239 0.8×	52	2.3k
Jose Ma. J. Alvir United States	21	3.1k 1.7×	1.2k 1.9×	823 2.1×	251 0.7×	738 2.5×	37	4.4k
Olli Kampman Finland	28	975 0.5×	487 0.8×	182 0.5×	210 0.6×	93 0.3×	112	2.1k
Rohan Ganguli United States	35	2.0k 1.1×	522 0.8×	588 1.5×	367 1.1×	236 0.8×	118	4.0k
Alan B. Ettinger United States	29	2.7k 1.5×	268 0.4×	340 0.8×	192 0.6×	180 0.6×	70	3.3k
Carmen Simonsen Norway	23	1.6k 0.9×	561 0.9×	380 0.9×	143 0.4×	284 1.0×	76	2.2k
Haruo Kashima Japan	31	1.2k 0.7×	429 0.7×	735 1.8×	99 0.3×	229 0.8×	126	2.7k
Antonio Benabarre Spain	28	3.7k 2.1×	1.1k 1.8×	255 0.6×	252 0.7×	79 0.3×	53	4.1k
Ross A. Baker United States	28	1.9k 1.1×	385 0.6×	179 0.4×	57 0.2×	289 1.0×	106	3.0k
René Ernst Nielsen Denmark	25	1.5k 0.8×	382 0.6×	137 0.3×	141 0.4×	225 0.8×	97	2.4k

Countries citing papers authored by Matthew Byerly

Since Specialization

Citations

This map shows the geographic impact of Matthew Byerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Byerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Byerly more than expected).

Fields of papers citing papers by Matthew Byerly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Byerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Byerly. The network helps show where Matthew Byerly may publish in the future.

Co-authorship network of co-authors of Matthew Byerly

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Byerly. A scholar is included among the top collaborators of Matthew Byerly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Byerly. Matthew Byerly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakonezny, Paul A., Janet C. Lindow, T. Scott Stroup, et al.. (2020). A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia. Schizophrenia Research. 220. 92–97. 1 indexed citations

Chen, Jiang, Michael Chen, Xia Wang, et al.. (2019). Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage. Journal of Neuroinflammation. 16(1). 210–210. 26 indexed citations

Lindow, Janet C., John H. Greist, Paul A. Nakonezny, et al.. (2019). Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled Trial. Journal of Medical Internet Research. 21(11). e14754–e14754. 32 indexed citations

Wang, Jun, Lauren E. Ethridge, Matthew W. Mosconi, et al.. (2017). A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. Journal of Neurodevelopmental Disorders. 9(1). 11–11. 112 indexed citations

Nakonezny, Paul A., David W. Morris, Tracy L. Greer, et al.. (2015). Evaluation of anhedonia with the Snaith–Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder. Journal of Psychiatric Research. 65. 124–130. 40 indexed citations

Nakonezny, Paul A., et al.. (2014). Curricula for Teaching Clinical Practice Guidelines in US Psychiatry Residency and Child and Adolescent Fellowship Programs: A Survey Study. Academic Psychiatry. 38(2). 198–204. 3 indexed citations

Nakonezny, Paul A., et al.. (2013). Subjective Quality of Life and Sexual Dysfunction in Outpatients With Schizophrenia or Schizoaffective Disorder. Journal of Sex & Marital Therapy. 39(4). 336–346. 18 indexed citations

Nakonezny, Paul A., Matthew Byerly, & Amit Kumar Pradhan. (2013). The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia. Psychiatry Research. 208(1). 9–14. 4 indexed citations

Stroup, T. Scott, Matthew Byerly, Henry A. Nasrallah, et al.. (2013). Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial. Schizophrenia Research. 146(1-3). 190–195. 26 indexed citations

10.

Byerly, Matthew, Paul A. Nakonezny, & A. John Rush. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research. 100(1-3). 60–69. 151 indexed citations

11.

Byerly, Matthew, Ronald N. Marcus, Quynh-Van Tran, et al.. (2008). Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study. Schizophrenia Research. 107(2-3). 218–222. 71 indexed citations

12.

Byerly, Matthew, et al.. (2007). Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia. Psychiatric Services. 58(6). 844–847. 99 indexed citations

13.

Byerly, Matthew, et al.. (2007). Antipsychotic Medication Adherence in Schizophrenia. Psychiatric Clinics of North America. 30(3). 437–452. 143 indexed citations

14.

Byerly, Matthew, Robert B. Fisher, Thomas Carmody, & A. John Rush. (2005). A Trial of Compliance Therapy in Outpatients With Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Psychiatry. 66(8). 997–1001. 67 indexed citations

15.

Nakonezny, Paul A. & Matthew Byerly. (2005). Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics. Schizophrenia Research. 82(1). 107–114. 40 indexed citations

16.

Byerly, Matthew, et al.. (2005). An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research. 81(2-3). 311–316. 49 indexed citations

17.

Byerly, Matthew, Mary Weber, Robert B. Fisher, et al.. (2004). An Open-Label Trial of Quetiapine for Antipsychotic-Induced Sexual Dysfunction. Journal of Sex & Marital Therapy. 30(5). 325–332. 35 indexed citations

18.

Stroup, T. Scott, Joseph P. McEvoy, M S Swartz, et al.. (2003). The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development. Schizophrenia Bulletin. 29(1). 15–31. 512 indexed citations breakdown →

19.

Byerly, Matthew, et al.. (2001). Antipsychotic Medications and the Elderly. Drugs & Aging. 18(1). 45–61. 68 indexed citations

20.

Byerly, Matthew & C. Lindsay DeVane. (1996). Pharmacokinetics of Clozapine and Risperidone. Journal of Clinical Psychopharmacology. 16(2). 177–187. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact